title: Effects of dietary supplementation with arachidonic acid rich oils on nerve conduction and blood flow in streptozotocin-diabetic rats.
abstract: Diabetes mellitus is associated with defective essential fatty acid desaturation. In experimental models this contributes to characteristic reductions in peripheral nerve conduction velocity (NCV) and blood flow, which may be corrected by dietary supplementation with gamma-linolenic acid (GLA) rich oils to bypass the delta-6 desaturation deficit. There is debate about the mechanism of this improvement, including whether it depends on synthesis of series 1 prostanoids derived from di-homo GLA or series 2 prostanoids from arachidonic acid (ARA). The aim was to assess the efficacy of two ARA-rich (approximately 39% content) oils in correcting neurovascular dysfunction in streptozotocin-induced diabetic rats. After 6 weeks of untreated diabetes, rats were treated for a further 2 weeks with 1% dietary oil supplements before assessment of sciatic motor NCV and endoneurial blood flow. NCV was 19% reduced in diabetic rats and this was largely (approximately 86%) corrected by both oil treatments. A 48% deficit in endoneurial nutritive blood flow with diabetes was approximately 70% reversed by the two oils, vascular conductance being in the non-diabetic range. Thus, nerve conduction and perfusion deficits in diabetic rats are corrected by ARA-rich oil treatment. The magnitudes of these changes were similar to expectations based on previous studies of GLA-rich oils, therefore it is likely that the neurovascular effect of increased synthesis of series 2 prostanoids makes a major contribution to the beneficial action of n-6 essential fatty acids in experimental diabetic neuropathy.
authors.affiliation: Department of Biomedical Sciences, University of Aberdeen, Marischal College, Scotland, UK.
authors.forename: M A
authors.initials: MA
authors.lastname: Cotter
authors.forename: N E
authors.initials: NE
authors.lastname: Cameron
mesh_terms: D000818:Animals; D016718:Arachidonic Acid / Q000494:pharmacology*; D001786:Blood Glucose / Q000032:analysis; D001835:Body Weight; D003921:Diabetes Mellitus, Experimental; D004042:Dietary Fats, Unsaturated / Q000494:pharmacology*; D005228:Fatty Acids, Essential / Q000494:pharmacology; D008041:Linoleic Acids; D008297:Male; D009431:Neural Conduction / Q000187:drug effects*; D031665:Oenothera biennis; D010938:Plant Oils; D051381:Rats; D017207:Rats, Sprague-Dawley; D012039:Regional Blood Flow / Q000187:drug effects*; D012584:Sciatic Nerve / Q000098:blood supply / Q000187:drug effects; D013311:Streptozocin; D017965:gamma-Linolenic Acid / Q000494:pharmacology
chemical_list: D001786:Blood Glucose; D004042:Dietary Fats, Unsaturated; D005228:Fatty Acids, Essential; D008041:Linoleic Acids; D010938:Plant Oils; D016718:Arachidonic Acid; C028498:evening primrose oil; D013311:Streptozocin; D017965:gamma-Linolenic Acid